SCI Pharmtech Corp.(TW:4119)
NT$48.95-1.85 (-1.21%)
TW:4119
SCI Pharmtech Corp. Revenue
NT$48.95
At close:-1.85 (-1.21%)
SCI Pharmtech Corp. (4119) Revenue
SCI Pharmtech Corp. Revenue
SCI Pharmtech Corp. had a revenue of 272.87M in the quarter ending Jun 30, 2026, with -27.39%. This bring the company's revenue in the last twelve months to 1.26B, Decreased 7.26%. In the fiscal year ending Dec 31, 2025, SCI Pharmtech Corp. had annual revenue of 1.34B with -11.81% growth.
- Revenue (ttm)
- 1.26B
- Revenue Growth
- -18.83%
- P/S Ratio
- 4.35
- Revenue/Employee
- TWD 6,652,079
- Employees
- 202
- Market Cap
- TWD 5.85B
Revenue Chart
SCI Pharmtech Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.34B | -180.02M | -11.81% |
| Dec 31, 2024 | 1.52B | 319.58M | 26.54% |
| Dec 31, 2023 | 1.20B | 304.42M | 33.83% |
| Dec 31, 2022 | 899.74M | 35.52M | 4.11% |
| Dec 31, 2021 | 864.22M | -1.83B | -67.86% |
| Dec 31, 2020 | 2.69B | 333.48M | 14.16% |
| Dec 31, 2019 | 2.36B | 415.83M | 21.44% |
| Dec 31, 2018 | 1.94B | 638.86M | 49.10% |
| Dec 31, 2017 | 1.30B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.